The results suggest that the five-year risk of major cardiovascular events such as heart attacks and the risk of end-stage kidney disease were reduced by 15% and 19%, respectively, for the patients taking GLP-1-RA drugs such as semaglutide (Ozempic) and tirzepatide (Mounjaro)
We recommend speaking with a professional if you have concerns
This action contributes to a feeling of fullness and reduced appetite
Any increase in proteinuria or decline in GFR should prompt evaluation for lupus nephritis flare versus coincidental change
C.BressendorffS.FriisP.CostantinoP.et al
It has high antioxidant activity, clearing free radicals, regulating immunity, improving resistance, wrinkling anti-aging, treating cancer, preventing adverse effects of radiation and so on